#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

CS

Editorial

Czech version

Published in: Diab Obez 2024; 24(1): 3
Category: Editorial

Labels

Diabetology Obesitology

Early use of SGLT2-inhibitors i in the treatment of type 2 diabetes mellitus

Integration of glycemic compensation markers, including glycemic variability in patients with diabetes mellitus

Metformin in the treatment of type 2 diabetes mellitus and its current position

Inklisiran and its role in lipid-lowering therapy

Slovak Diabetes Society recommendations for diabetes education

Type 2 diabetes mellitus and obesity – dangerous companions

Coexistence of SGLT2 inhibitors and GLP-1 receptor agonists in the treatment of a patient with type 2 diabetes mellitus

Current position of GLP-1 receptor agonists in type 2 diabetes mellitus treatment

Long-term sustainability of metabolic compensation in telemedicine use – results of 18 months follow-up

Diabetic distress from clinical diabetology view

6th National SDS Symposium: Where are we moving with technology in diabetology in Slovakia?

Pilot project for early detection of hyperglycemia, prediabetes and/or diabetes mellitus in insured persons of VšZP, a.s., and throughout Slovakia in specialist outpatient clinics of diabetologists in diabetes-naïve patients: report

Advanced Technologies & Treatments for Diabetes 2024, Florencia – sumár z kongresu

Diabetics from all over Slovakia on reconditioning stays

Article was published in

Diabetes and obesity

Issue 1

2024 Issue 1

Most read in this issue

Topics

Journals

#ADS_BOTTOM_SCRIPTS#